文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Annette Baumhauer
发表
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Masatoshi Kudo, Osamu Yokosuka, Gianluca Masi, 2017, The Lancet.